183 related articles for article (PubMed ID: 9238058)
1. A natural polymorphism in beta-lactamase is a global suppressor.
Huang W; Palzkill T
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8801-6. PubMed ID: 9238058
[TBL] [Abstract][Full Text] [Related]
2. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
Sideraki V; Huang W; Palzkill T; Gilbert HF
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
[TBL] [Abstract][Full Text] [Related]
3. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
Kather I; Jakob RP; Dobbek H; Schmid FX
J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
[TBL] [Abstract][Full Text] [Related]
4. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
Winkler ML; Bonomo RA
Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
[TBL] [Abstract][Full Text] [Related]
5. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
[TBL] [Abstract][Full Text] [Related]
6. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
[TBL] [Abstract][Full Text] [Related]
7. [Investigation the role of mutations M182T and Q39K in structure of beta-lactamase TEM-72 by molecular dynamics method].
Shcherbinin DS; Rubtsova MY; Grigorenko VG; Uporov IV; Veselovsky AV; Egorov AM
Biomed Khim; 2016 Jul; 62(5):527-534. PubMed ID: 27797327
[TBL] [Abstract][Full Text] [Related]
8. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
[TBL] [Abstract][Full Text] [Related]
9. Selection strategy for site-directed mutagenesis based on altered beta-lactamase specificity.
Andrews CA; Lesley SA
Biotechniques; 1998 Jun; 24(6):972-4, 976, 978 passim. PubMed ID: 9631188
[TBL] [Abstract][Full Text] [Related]
10. High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
De Wals PY; Doucet N; Pelletier JN
Protein Sci; 2009 Jan; 18(1):147-60. PubMed ID: 19177359
[TBL] [Abstract][Full Text] [Related]
11. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of laboratory mutants of extended-spectrum beta-lactamase TEM-60.
Caporale B; Franceschini N; Perilli M; Segatore B; Rossolini GM; Amicosante G
Antimicrob Agents Chemother; 2004 Sep; 48(9):3579-82. PubMed ID: 15328132
[TBL] [Abstract][Full Text] [Related]
13. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
Patel MP; Fryszczyn BG; Palzkill T
Antimicrob Agents Chemother; 2015 Nov; 59(11):6741-8. PubMed ID: 26282414
[TBL] [Abstract][Full Text] [Related]
15. Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.
Papp-Wallace KM; Becka SA; Taracila MA; Winkler ML; Gatta JA; Rholl DA; Schweizer HP; Bonomo RA
Antimicrob Agents Chemother; 2016 Feb; 60(2):777-88. PubMed ID: 26596949
[TBL] [Abstract][Full Text] [Related]
16. Natural and Synthetic Suppressor Mutations Defy Stability-Activity Tradeoffs.
Lee S; Okoye CN; Biesbrock D; Harris EC; Miyasaki KF; Rilinger RG; Tso M; Hart KM
Biochemistry; 2022 Mar; 61(5):398-407. PubMed ID: 35142509
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis on TEM-1 beta-lactamase: role of Glu166 in catalysis and substrate binding.
Delaire M; Lenfant F; Labia R; Masson JM
Protein Eng; 1991 Oct; 4(7):805-10. PubMed ID: 1798703
[TBL] [Abstract][Full Text] [Related]
18. The structural bases of antibiotic resistance in the clinically derived mutant beta-lactamases TEM-30, TEM-32, and TEM-34.
Wang X; Minasov G; Shoichet BK
J Biol Chem; 2002 Aug; 277(35):32149-56. PubMed ID: 12058046
[TBL] [Abstract][Full Text] [Related]
19. The impact of long-distance mutations on the Ω-loop conformation in TEM type β-lactamases.
Shcherbinin D; Veselovsky A; Rubtsova M; Grigorenko V; Egorov A
J Biomol Struct Dyn; 2020 May; 38(8):2369-2376. PubMed ID: 31241429
[TBL] [Abstract][Full Text] [Related]
20. Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.
Marciano DC; Pennington JM; Wang X; Wang J; Chen Y; Thomas VL; Shoichet BK; Palzkill T
J Mol Biol; 2008 Dec; 384(1):151-64. PubMed ID: 18822298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
